Telmisartan and ramipril were equivalent, but their combination increased adverse events in vascular disease or diabetes: Commentary

Research output: Contribution to journal › Short survey › peer-review

Access to Document

@article{0af20d6f0a29497ea83c83beb34412a1,

title = "Telmisartan and ramipril were equivalent, but their combination increased adverse events in vascular disease or diabetes: Commentary",

author = "Farkouh, {Michael E.} and Sameer Bansilal",

year = "2008",

month = oct,

doi = "10.1136/ebm.13.5.147",

language = "English",

volume = "13",

pages = "147",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "5",

}

TY - JOUR

T1 - Telmisartan and ramipril were equivalent, but their combination increased adverse events in vascular disease or diabetes

T2 - Commentary

AU - Farkouh, Michael E.

AU - Bansilal, Sameer

PY - 2008/10

Y1 - 2008/10

UR - http://www.scopus.com/inward/record.url?scp=55049091861&partnerID=8YFLogxK

U2 - 10.1136/ebm.13.5.147

DO - 10.1136/ebm.13.5.147

M3 - Short survey

AN - SCOPUS:55049091861

SN - 1356-5524

VL - 13

SP - 147

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

IS - 5

ER -